Beijing Sunho Pharmaceutical Co (BJSE:430017) ROCE % : 6.35% (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Beijing Sunho Pharmaceutical Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Beijing Sunho Pharmaceutical Co's annualized ROCE % for the quarter that ended in Mar. 2024 was 6.35%.

Beijing Sunho Pharmaceutical Co ROCE % Historical Data

The historical data trend for Beijing Sunho Pharmaceutical Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Sunho Pharmaceutical Co ROCE % Chart

Beijing Sunho Pharmaceutical Co Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

ROCE %

Get a 7-Day Free Trial

6.16

9.00

7.46

6.37

7.27

Beijing Sunho Pharmaceutical Co Quarterly Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial															5.91	10.31	5.62	6.19	6.35

Beijing Sunho Pharmaceutical Co ROCE % Calculation

Beijing Sunho Pharmaceutical Co's annualized ROCE % for the fiscal year that ended in Dec. 2022 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	88.144	/	( ( (1311.513 - 122.039)	+	(1395.162 - 158.291) )	/ 2 )
	=	88.144	/	( (1189.474	+	1236.871)	/ 2 )
	=	88.144	/	1213.1725
	=	7.27 %

Beijing Sunho Pharmaceutical Co's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	102.548	/	( ( (1799.788 - 194.961)	+	(1828.859 - 204.22) )	/ 2 )
	=	102.548	/	( ( 1604.827	+	1624.639 )	/ 2 )
	=	102.548	/	1614.733
	=	6.35 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

Beijing Sunho Pharmaceutical Co (BJSE:430017) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Beijing Sunho Pharmaceutical Co ROCE % Related Terms

Thank you for viewing the detailed overview of Beijing Sunho Pharmaceutical Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Beijing Sunho Pharmaceutical Co (BJSE:430017) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beijing Sunho Pharmaceutical Co Ltd (BJSE:430017) » Definitions » ROCE %

Traded in Other Exchanges

N/A

Address

No. 18, Zhonghe Street, Beijing Economic and Technological Development Zone, Beijing, CHN, 100176

Website

http://www.sunho.com.cn

Beijing Sunho Pharmaceutical Co Ltd engages in the research and development, production, and sales of pharmaceutical preparations while providing CMC/CMO integrated services for pharmaceutical preparation manufacturers and innovative drug R&D enterprises. The company produces small-volume injections, freeze-dried powder injections, hard capsules, tablets, and other products.

Beijing Sunho Pharmaceutical Co (BJSE:430017) Headlines

No Headlines